Reinventing the Injection Sequence
Medtech Automation is an Accelerating Theme
- 23-27% of Orthopedic Surgeons have required time of from work due to injury or illness
- 8% of Orthopedic Surgeons required longer than 3 weeks off because of injury.
- 36% of injured surgeons reported pain from an occupational injury “at least “minimally impacted” their performance
- 43% of injured surgeons were forced to take a break from work.
The VeloJect Generation of Injection Technology
- Reproducibly delivers pharmaceutical compounds to the targeted tissue locations.
- Enables convenient and comfortable application of fluids in precisely prescribed dosages.
- Facilitates improved visualization and access to deeper tissue with greater confidence and less obscuration.
- Significantly reduces the fatigue and fine-muscle strain associated with manual manipulation of plunger devices.
- Enables a faster surgical procedure with less physical effort and greater confidence in outcome certainty.
Pain Management: Opinions, Friction & Uncertainties Abound
- Skepticism among HCPs and hospital buyers persists around the clinical efficacy and reproducibility of Exparel®
- Selected community observations suggest that ~60% of the time, Exparel® works approximately 36 hours.
- Surgeons often rely on a larger 20-gauge needle due to time constraints and physical fatigue concerns.
- Many physicians accept the clinical uncertainties because pain control is so important for their patients and their paying institutions.
- But many more do not.
Software Controlled, High-Pressure Positive Displacement Pump
Intellectual Property & Know-How
- US Patent No. 11,229,750
- Track 1 continuation filings: 17/575,601 and 17/575,604
- US Provisional Patents (63/006,056; 63/252,607)
- Additional OUS filings imminent